Foreign trade creditors supplying pharmaceutical products into the Georgian market operate in a jurisdiction that is more commercially accessible than many of its regional neighbours, yet contains enforcement mechanics and sector-specific regulatory constraints that routinely catch foreign suppliers off-guard. Georgia's civil procedure framework is codified, its commercial courts have improved materially over the past decade, and the country's obligations under the EU–Georgia Association Agreement have introduced a degree of harmonisation with European standards — but none of this removes the practical exposure that arises when a Georgian pharmaceutical distributor or pharmacy chain fails to settle a trade account. For creditors headquartered in Russia, Germany, Switzerland, or any other jurisdiction with active supply relationships in the Georgian market, understanding the pre-litigation, litigation, and enforcement sequence — and the sector-specific licensing and regulatory overlaps — is the prerequisite to any realistic recovery strategy.
This checklist sets out the key compliance and procedural steps a foreign trade creditor should work through before and during debt recovery proceedings in Georgia's pharmaceuticals sector. Each item is framed as a practical action point, with a note on the legal or regulatory consequence where the risk is material.
Before any recovery action, the creditor must confirm that the underlying contract, invoice series, or promissory note constitutes an enforceable obligation under Georgian law — not merely under the law of the creditor's home jurisdiction.
Georgian civil law follows a civil-law tradition and applies the principle of freedom of contract. Foreign-law clauses in supply agreements are generally recognised, but Georgian courts will apply Georgian law to procedural matters and may re-characterise certain contractual provisions — particularly penalty clauses and deemed-acceptance terms — under domestic public policy norms.
For pharmaceutical supply agreements specifically, the contract should accurately describe the goods using the International Nonproprietary Name (INN) or the Georgian Medicines Agency-registered product designation. Agreements that reference product descriptions inconsistent with the registration dossier may face challenges at the documentary stage.
Practical steps: obtain a certified Georgian translation of the contract; confirm that the debt amount is quantified (not subject to future adjustment clauses that have not yet triggered); verify that the limitation period has not elapsed.
Note: Georgian civil procedure applies a general limitation period of three years for contractual claims. In pharmaceutical supply relationships involving recurring invoices, the limitation period runs from each invoice's due date individually — creditors who delay pursuing aged invoices risk losing the right to recover them even if the overall trading relationship is ongoing.
A Georgian pharmaceutical distributor or pharmacy chain operates under licences issued by the Medicines Agency of Georgia. The debtor's continued regulatory standing is directly relevant to recoverability.
Licence suspension or revocation — which can occur following a pharmacovigilance failure, quality incident, or GMP inspection result — will typically precede formal insolvency by months. A creditor who monitors only court filings and misses the regulatory signal loses the window for voluntary settlement and early enforcement.
Practical steps: check the Georgian Medicines Agency's public register for the debtor's current licence status; verify the debtor's registration with the Revenue Service of Georgia; run a court database search at the Court of Justice of Georgia's e-filing portal for any pending claims or enforcement proceedings against the debtor.
Note: Georgian insolvency legislation — the Law of Georgia on Insolvency Proceedings — provides for a rehabilitation procedure and a liquidation procedure. Once a debtor enters formal insolvency, unsecured trade creditors join a queue that in practice yields limited recovery. The practical window for full recovery is typically the period before formal insolvency filing.
[CTA: If your Georgian pharmaceutical counterparty is showing early signs of financial distress, an immediate assessment of your recovery options is time-critical — make an enquiry: info@vetrovpartners.com | WhatsApp/Telegram: +7 (983) 510-38-76]
Pharmaceutical supply chains into Georgia involve a layer of documentation that is not present in general goods trade. The Medicines Agency requires that imported medicinal products are accompanied by a certificate of conformity, a certificate of analysis for each batch, and — for prescription pharmaceuticals — confirmation of the import authorisation or re-export licence where applicable.
If the supply agreement was performed and the goods were delivered, the creditor will need to demonstrate delivery and acceptance for the purposes of a Georgian court claim. In pharmaceutical supply relationships, the delivery and acceptance record intersects with the regulatory documentation: a debtor who raises a quality objection based on batch documentation gaps may seek to set off or reduce the claimed sum.
Practical steps: compile the full batch documentation for each unpaid delivery; verify that the goods were registered with the Georgian Medicines Agency at the time of delivery; obtain the signed CMR, delivery note, or equivalent acceptance record for each consignment.
Note: Georgian procedural law places the burden of proving delivery and acceptance on the creditor. A gap in batch documentation — even where the goods were clearly delivered and used — may be exploited by a debtor as a counterclaim or a procedural delay tactic. Pre-litigation documentation review with Georgian counsel is advisable before filing.
Debt recovery claims in Georgia are heard by common courts of general jurisdiction — there is no separate commercial court system. First-instance claims above a threshold value are heard by the district or city courts; appeal lies to the Court of Appeals, and cassation lies to the Supreme Court of Georgia.
Georgian civil procedure provides for an expedited payment order for undisputed monetary claims supported by documentary evidence. Where the debtor is likely to contest, a standard adversarial claim is the appropriate route.
Many pharmaceutical distribution agreements in the Georgian market contain arbitration clauses referring disputes to the International Arbitration Court at the Georgian Chamber of Commerce and Industry, or — in cross-border agreements with European or Russian counterparties — to international arbitration seats. Foreign creditors should check the governing dispute resolution clause before filing in the Georgian courts, as filing in the wrong forum may trigger a jurisdictional objection.
Practical steps: identify the dispute resolution clause in the supply agreement; confirm whether any arbitration clause is mandatory or permissive; if the clause is ambiguous, obtain early advice on whether a Georgian court would exercise jurisdiction.
Note: If the supply agreement contains a mandatory arbitration clause and the creditor files in a Georgian court without the debtor's consent, the debtor may obtain a stay of proceedings. This does not end the creditor's right to recover but extends the timeline materially.
Georgian civil procedure provides for interim relief (precautionary measures) to prevent asset dissipation before or during proceedings. The standard measures available include the freezing of bank accounts, the prohibition on asset disposal, and the registration of a claim against immovable property.
For pharmaceutical trade creditors, the debtor's attachable assets may include: receivables from pharmacy chains or the State Healthcare Fund of Georgia; inventory held in licensed storage; vehicles and distribution equipment; and any real property held in the name of the distributor entity.
Practical steps: conduct a corporate registry and immovable property registry search via the National Agency of Public Registry; assess whether a bank account freeze is appropriate given the likely size of the claim relative to the debtor's operating cash flow; consult Georgian counsel on the evidentiary threshold for obtaining interim relief without giving the debtor advance notice.
Note: Georgian courts may require the creditor to post counter-security when granting interim relief on an ex parte basis. The amount varies by court and by the nature of the assets subject to the measure. Foreign creditors should factor this into liquidity planning before applying for precautionary measures.
[CTA: For creditors assessing whether interim relief is available against a Georgian pharmaceutical debtor, our team can coordinate a rapid assets review with Georgian counsel — make an enquiry: info@vetrovpartners.com | WhatsApp/Telegram: +7 (983) 510-38-76]
Pharmaceutical distributors in Georgia frequently operate under credit terms that include volume rebates, return rights for short-dated or recalled stock, price-protection clauses, and co-promotion contribution arrangements. These contractual features create a realistic risk that a debtor responding to a debt recovery claim will assert a set-off or counterclaim that reduces — or eliminates — the net recoverable sum.
Before filing, the creditor should map all outstanding credits, debit notes, and unresolved claims that the debtor might raise. This includes: batch return claims; alleged overpayments or pricing disputes under index-linked formulae; and any unresolved marketing support or co-promotion invoices.
Practical steps: reconcile the trading account in full before quantifying the claim; review correspondence for any outstanding quality or delivery objections raised by the debtor that have not been formally resolved; obtain a legal opinion on whether Georgian law would permit the debtor to set off unliquidated claims against a liquidated debt.
Note: Under Georgian civil law, a set-off of a liquidated counterclaim against a liquidated debt may be asserted unilaterally by the debtor — it is not subject to court permission. An unliquidated or disputed counterclaim requires court adjudication. Creditors who enter litigation without a full account reconciliation risk an adverse costs order if the recoverable sum is materially lower than the amount claimed.
Where the creditor's assets and operations — or the debtor's parent company's assets — are located outside Georgia, the enforceability of a Georgian judgment in the relevant foreign jurisdiction becomes a material planning consideration.
Georgia does not have a bilateral treaty on mutual enforcement of judgments with Russia. A Georgian court judgment against a Georgian debtor must be recognised by a Russian court through a discretionary recognition procedure — and reciprocity is the primary test. In practice, Georgian judgments have a limited enforcement track record in Russian courts.
If the debtor has assets in EU member states, the EU–Georgia Association Agreement does not itself create a judgment recognition mechanism — creditors must use the domestic procedure of the relevant EU state, which varies materially by country.
Practical steps: map where the debtor and any guarantor or parent entity hold material assets; assess whether cross-border enforcement is realistic for those jurisdictions before committing to Georgian court proceedings; consider whether a judgment or arbitral award would be more enforceable in the key asset jurisdictions.
Note: An arbitral award issued under recognised institutional arbitration rules may be more readily enforceable across multiple jurisdictions than a Georgian court judgment, because Georgia is a party to the New York Convention on the Recognition and Enforcement of Foreign Arbitral Awards. Foreign creditors whose agreements permit a choice of forum should weigh this factor before proceedings are initiated.
[CTA: For cross-border recovery strategies involving Georgian debtors and assets held in Russia or other jurisdictions, please discuss your matter in confidence: info@vetrovpartners.com | WhatsApp/Telegram: +7 (983) 510-38-76 | t.me/vitvetcom]
Q: What is the general limitation period for a trade debt claim in Georgia?
A: The general limitation period for a contractual debt claim under Georgian civil law is three years, running from the date on which the obligation fell due. For pharmaceutical supply relationships with rolling monthly invoice terms, the limitation period applies to each invoice individually from its due date — not from the end of the trading relationship. Creditors with aged receivables should prioritise older invoices and obtain an assessment of whether any limitation period has already elapsed before filing. Georgian courts apply limitation rules strictly, and a debtor can raise limitation as a complete defence at any stage of first-instance proceedings.
Q: Can a foreign creditor obtain a court order freezing a Georgian debtor's bank accounts before the main hearing?
A: Yes — Georgian civil procedure permits a creditor to apply for precautionary measures, including a bank account freeze, before or during the main proceedings. The applicant must demonstrate the plausibility of the claim and a real risk of asset dissipation. Georgian courts may require counter-security from the applicant, particularly on ex parte applications. The procedure is not automatic and requires supporting evidence; a creditor with documentary proof of the debt and evidence of debtor financial distress is in a stronger position. Local Georgian counsel must file the application, as procedural standing before Georgian courts requires Georgian bar admission.
Q: Does a Georgian court judgment automatically bind the debtor's parent company or guarantor?
A: No. A Georgian court judgment binds only the named respondent — the specific legal entity against which the claim was filed. Extending liability to a parent company or guarantor requires either a separate contractual guarantee, a piercing-of-the-corporate-veil claim under Georgian law in limited circumstances of abuse, or a separate claim against the guarantor entity. In pharmaceutical distribution structures, where a local distributor is a subsidiary of a larger group, creditors should assess whether a parent guarantee was obtained at the time of contracting — and if not, whether the parent's conduct during the trading relationship gives rise to any independent liability argument.
Vetrov & Partners is a Russian boutique law firm established in 2009, recognised by Pravo-300 for eight consecutive years and listed as a trusted adviser by the German Consulate General in Novosibirsk.
The firm's cross-border disputes practice advises foreign trade creditors and institutional investors pursuing recovery across the post-Soviet and Caucasus region, coordinating with trusted local counsel in Georgia, Armenia, Kazakhstan, and Uzbekistan. On Georgian matters, the firm works with Georgian-qualified practitioners and provides cross-border strategic oversight — including coordination of parallel enforcement action in Russia and other jurisdictions where the debtor or its affiliates hold assets.
With over 1,000 matters handled since inception, the team brings direct partner involvement to every engagement and maintains English-language communication throughout.
Enquiries: info@vetrovpartners.com | WhatsApp / Telegram: +7 (983) 510-38-76 | t.me/vitvetcom
This publication is provided for informational purposes only and does not constitute legal advice under Russian or any other applicable law. The information herein should not be relied upon as a substitute for professional legal counsel tailored to your specific circumstances. Vetrov & Partners is a Russian-qualified law firm. For matters governed by foreign law or requiring local admission in another jurisdiction, we collaborate with trusted counsel in the relevant jurisdiction. For advice regarding your particular situation, please contact info@vetrovpartners.com.
— Giorgi Kavtaradze Contributing Regional Analyst — Georgia, Commercial Disputes & Enforcement, Vetrov & Partners vetrovpartners.com/contributions/